Get started
Author

Kazuhide Onoguchi

Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors
2021 · Koji Onomoto, Kazuhide Onoguchi, et al. · Cellular and Molecular Immunology · 431
PDF
Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism
2007 · Kazuhide Onoguchi, Mitsutoshi Yoneyama, et al. · Journal of Biological Chemistry · 355
PDF
Virus-Infection or 5′ppp-RNA Activates Antiviral Signal through Redistribution of IPS-1 Mediated by MFN1
2010 · Kazuhide Onoguchi, Koji Onomoto, et al. · PLoS Pathogens · 182
PDF
Retinoic Acid-Inducible Gene-I-Like Receptors
2010 · Kazuhide Onoguchi, Mitsutoshi Yoneyama, et al. · Journal of Interferon & Cytokine Research · 101
Leader-Containing Uncapped Viral Transcript Activates RIG-I in Antiviral Stress Granules
2016 · Seong-Wook Oh, Koji Onomoto, et al. · PLoS Pathogens · 83
PDF
Triggering antiviral response by RIG-I-related RNA helicases
2007 · Takashi Fujita, Kazuhide Onoguchi, et al. · Biochimie · 73
Single-cell sequencing on CD8+ TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer/testis antigen in non-small cell lung cancer
2023 · Hiroyasu Komuro, Shuichi Shinohara, et al. · Journal for ImmunoTherapy of Cancer · 42
PDF
Type I Interferon Production Induced by RIG-I-Like Receptors
2010 · Koji Onomoto, Kazuhide Onoguchi, et al. · Journal of Interferon & Cytokine Research · 30
Functional Characterization of Domains of IPS-1 Using an Inducible Oligomerization System
2013 · Shiori Takamatsu, Kazuhide Onoguchi, et al. · PLoS ONE · 24
PDF
Correction: Leader-Containing Uncapped Viral Transcript Activates RIG-I in Antiviral Stress Granules
2016 · Seong-Wook Oh, Koji Onomoto, et al. · PLoS Pathogens · 14
PDF
Candidate tumor-specific CD8 + T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis
2024 · Yusuke Sugita, Daisuke Muraoka, et al. · OncoImmunology · 13
A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial
2026 · Christian Ottensmeier, Jean-Pierre Delord, et al. · Nature Communications · 1
PDF
650 Randomized phase I trial of adjuvant individualized TG4050 vaccine in patients with locally advanced resected HPV-negative head and neck squamous cell carcinoma (HNSCC)
2024 · Christophe Le Tourneau, Jean-Pierre Delord, et al. · Regular and Young Investigator Award Abstracts · 1
Abstract LB205: Feasibility and immunogenicity of adjuvant TG4050, a patient tailored cancer vaccine in head and neck and ovarian cancer
2023 · Ana Lalanne, Camille Jamet, et al. · Cancer Research · 1
Abundant CD8+ tumor-infiltrating lymphocytes in glioblastoma harbor distinct exhaustion signatures in potentially reactive subsets
2026 · Takanari Okamoto, Ryo Mizuta, et al. · British Journal of Cancer
Generative AI-Guided Design of High-Affinity T Cell Receptors
2026 · Martin Renqiang Min, Tianxiao Li, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: immunogenicity and efficacy from a randomized Phase I trial
2026 · C. Ottensmeier, J-P. Delord, et al. · medRxiv
PDF
Functional and structural analysis of KK-LC-1-specific T cell receptors from patients with lung Cancer for immunotherapy
2025 · Yasunori Fukushima, Yizheng Wang, et al. · Cellular Immunology
162 A whole-genome-informed pipeline for neoantigen discovery in solid tumors: integrating SNV, splice variant, and exon-transposon junction analysis to enable personalized cancer vaccines
2025 · Jun Masuda, Kazuma Kiyotani, et al. · Regular and Young Investigator Award Abstracts
PDF
502 Profiling of the neoantigen-specific T cell response after adjuvant TG4050 individualized therapeutic vaccination in a randomized phase I trial for locally advanced resected HPV-negative HNSCC
2025 · Christophe Le Tourneau, Ana Lalanne, et al. · Regular and Young Investigator Award Abstracts
PDF
1230 Design of enhanced TCR against cancer antigens using an AI system
2024 · Martin Renqiang Min, Kazuhide Onoguchi, et al. · Regular and Young Investigator Award Abstracts
Immu-03. Exploring Cancer-specific T Cells and Antigens in Glioblastoma Based on Single-cell Sequencing of Cd8+ Tils
2024 · Takanari Okamoto, Ryo Mizuta, et al. · Neuro-Oncology
PDF
[Self or non-self RNA sensing mechanism of innate antiviral immunity].
2009 · Kazuhide Onoguchi, Mitsutoshi Yoneyama · PubMed
Mitochondrial dynamics and innate antiviral responses regulated by RIG-I-like receptor
2009 · Kazuhide Onoguchi, Mitsutoshi Yoneyama, et al. · Cytokine
Works count: 24
Citation count: 1,351
H-index: 11
I10-index: 11
Year
Topic
Type